1. Angiotensin receptor neprilysin inhibition versus individualized RAAS blockade: design and rationale of the PARALLAX trial. (15th April 2020) Authors: Wachter, Rolf; Shah, Sanjiv J.; Cowie, Martin R.; Szecsödy, Peter; Shi, Victor; Ibram, Ghionul; Zhao, Ziqiang; Gong, Jianjian; Klebs, Sven; Pieske, Burkert Journal: ESC heart failure Issue: Volume 7:Number 3(2020) Page Start: 856 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Baseline characteristics of patients in the PARALLAX trial: insights into quality of life and exercise capacity in heart failure with preserved ejection fraction. (26th July 2021) Authors: Shah, Sanjiv J.; Cowie, Martin R.; Wachter, Rolf; Szecsödy, Peter; Shi, Victor; Ibram, Ghionul; Hu, Mo; Zhao, Ziqiang; Gong, Jianjian; Pieske, Burkert Journal: European journal of heart failure Issue: Volume 23:Number 9(2021) Page Start: 1541 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Impact of Sacubitril/Valsartan Compared With Ramipril on Cardiac Structure and Function After Acute Myocardial Infarction: The PARADISE-MI Echocardiographic Substudy. Issue 14 (9th September 2022) Authors: Shah, Amil M.; Claggett, Brian; Prasad, Narayana; Li, Guichu; Volquez, Mayra; Jering, Karola; Cikes, Maja; Kovacs, Attila; Mullens, Wilfried; Nicolau, Jose C.; Køber, Lars; van der Meer, Peter; Jhund, Pardeep S.; Ibram, Ghionul; Lefkowitz, Martin; Zhou, Yinong; Solomon, Scott D.; Pfeffer, Marc A. Journal: Circulation Issue: Volume 146:Issue 14(2022) Page Start: 1067 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗